Global Gut Microbiome Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Gut Microbiome Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
The gut microbiome is a vast ecosystem of organisms such as bacteria, yeasts, fungi, viruses and protozoans that live in our digestive pipes, which collectively weigh up to 2kg (heavier than the average brain). The report is about Gut Microbiome Therapeutics market.
Gut Microbiome report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Gut Microbiome market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Human and Animal are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Gut Microbiome industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Gut Microbiome key companies include Viome, Carbiotix, Ixcela, Inc, Novome Biotechnologies, Kintai Therapeutics, ProDigest, Caelus Health, LNC Therapeutics and AnimalBiome, etc. Viome, Carbiotix, Ixcela, Inc are top 3 players and held % share in total in 2022.
Gut Microbiome can be divided into Obesity, Inflammatory Bowel Disease (IBD), Diabetes and Others, etc. Obesity is the mainstream product in the market, accounting for % share globally in 2022.
Gut Microbiome is widely used in various fields, such as Human and Animal, etc. Human provides greatest supports to the Gut Microbiome industry development. In 2022, global % share of Gut Microbiome went into Human filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Gut Microbiome market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Viome
Carbiotix
Ixcela, Inc
Novome Biotechnologies
Kintai Therapeutics
ProDigest
Caelus Health
LNC Therapeutics
AnimalBiome
Assembly Biosciences
Enterome BioScience
Segment by Type
Obesity
Inflammatory Bowel Disease (IBD)
Diabetes
Others
Human
Animal
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Gut Microbiome market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Gut Microbiome introduction, etc. Gut Microbiome Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Gut Microbiome market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Gut Microbiome report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Gut Microbiome market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Human and Animal are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Gut Microbiome industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Gut Microbiome key companies include Viome, Carbiotix, Ixcela, Inc, Novome Biotechnologies, Kintai Therapeutics, ProDigest, Caelus Health, LNC Therapeutics and AnimalBiome, etc. Viome, Carbiotix, Ixcela, Inc are top 3 players and held % share in total in 2022.
Gut Microbiome can be divided into Obesity, Inflammatory Bowel Disease (IBD), Diabetes and Others, etc. Obesity is the mainstream product in the market, accounting for % share globally in 2022.
Gut Microbiome is widely used in various fields, such as Human and Animal, etc. Human provides greatest supports to the Gut Microbiome industry development. In 2022, global % share of Gut Microbiome went into Human filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Gut Microbiome market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Viome
Carbiotix
Ixcela, Inc
Novome Biotechnologies
Kintai Therapeutics
ProDigest
Caelus Health
LNC Therapeutics
AnimalBiome
Assembly Biosciences
Enterome BioScience
Segment by Type
Obesity
Inflammatory Bowel Disease (IBD)
Diabetes
Others
Segment by Application
Human
Animal
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Gut Microbiome market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Gut Microbiome introduction, etc. Gut Microbiome Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Gut Microbiome market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.